Drawing for PRESSIAL

USPTO serial 79118605

PRESSIAL

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRESSIAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cardiovascular diseasesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 18, 2013DETHDEATH OF INTERNATIONAL REGISTRATION—
Feb 8, 2013GPNXNOTIFICATION PROCESSED BY IB—
Jan 15, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 18, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2012OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 12, 2012OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 28, 2012NPUBNOTICE OF PUBLICATION—
Nov 8, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 31, 2012DOCKASSIGNED TO EXAMINER—
Oct 30, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 26, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 24, 2012LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 23, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance